Atlas Capital Advisors’s Diebold Nixdorf Incorporated DBD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-650
Closed -$1.48K 1023
2022
Q2
$1.48K Hold
650
﹤0.01% 920
2022
Q1
$4.38K Hold
650
﹤0.01% 807
2021
Q4
$5.88K Hold
650
﹤0.01% 785
2021
Q3
$6.57K Hold
650
﹤0.01% 779
2021
Q2
$8.35K Hold
650
﹤0.01% 769
2021
Q1
$9.18K Buy
+650
New +$8.95K ﹤0.01% 690

Other funds holding DBD

Atlas Capital Advisors's DBD Position: Q3 2022 in Review

Atlas Capital Advisors sold out of Diebold Nixdorf Incorporated (DBD) in Q3 2022, closing a stake of 650 shares — an estimated $1.48K sold.

Atlas Capital Advisors first reported a position in DBD in Q1 2021 and held it in 6 quarters. The position peaked at $9.18K in Q1 2021. 165 funds tracked by Wall St. Rank hold DBD as of Q3 2022.

  • Atlas Capital Advisors reported no remaining Diebold Nixdorf Incorporated position as of Q3 2022 after selling out during the quarter.
  • Atlas Capital Advisors sold 650 Diebold Nixdorf Incorporated shares in Q3 2022, an estimated $1.48K.
  • Atlas Capital Advisors first reported a position in Diebold Nixdorf Incorporated in Q1 2021 and held it in 6 quarters.
  • Atlas Capital Advisors's Diebold Nixdorf Incorporated position peaked at $9.18K in Q1 2021.
  • 165 funds tracked by Wall St. Rank held Diebold Nixdorf Incorporated as of Q3 2022.

Based on Atlas Capital Advisors's 13F filing for Q3 2022, filed 8 Nov 2022.